Skip to main content
Equibles

JANE STREET GROUP, LLC

Position in VANI — Vivani Medical, Inc.

CIK 1595888 NEW YORK, NY
Back to VANI Full portfolio

Position in VANI

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$10,619
-$49,126 QoQ
Shares Held
10,619
-78.1% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VANI Over Time

Shares Held

Position Value (USD)

Derivatives in VANI

reported options exposure · as of Dec 31, 2021
CallValue
$0
CallShares
0
PutValue
$0
PutShares
24,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $1,373,713,627 across 292 Biotechnology names.

# Ticker Company Shares Value (USD) Open
1 BBIO
BridgeBio Pharma, Inc.
 2,934,193 $218,538,693
2 MDGL
Madrigal Pharmaceuticals, Inc.
 191,541 $102,847,939
3 AXSM
Axsome Therapeutics, Inc.
 403,995 $98,885,855
4 TGTX
Tg Therapeutics, Inc.
 1,752,646 $96,290,370
5 EXEL
Exelixis, Inc.
 1,402,438 $76,306,651
6 QURE
uniQure N.V.
 1,610,483 $74,178,846
7 HALO
Halozyme Therapeutics, Inc.
 694,684 $54,372,915
8 TVTX
Travere Therapeutics, Inc.
 938,699 $53,327,489

All Filings in VANI

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $10,619 10,619
2025-12-31 $59,745 48,574
2025-06-30 $22,672 17,576
2024-12-31 $66,304 57,159
2023-12-31 $16,343 16,023
2023-09-30 $21,558 21,136
2023-06-30 $23,706 19,592
2022-12-31 $18,773 22,086